The GIST Cancer Journal Arrives
The Life Raft Group is pleased to announce the release of the first issue of The GIST Cancer Journal, the official journal of the Life Raft Group and the first academic journal devoted solely to GIST.
ASCO features many updates on GIST trials
ASCO features many updates on GIST trials. Promising results for the immunotherapy approach to treating cancer dominated the annual conference of the ASCO and represent one of the biggest developments in cancer research since the advent [...]
Anxiety Stays Long After Cancer
GIST patients deal with anxiety on a daily basis. A recent article in the New York Times has uncovered that anxiety actually lingers long after cancer.
First GDOL Chicago hits a homerun!
Our first Chicago GIST Day of Learning (GDOL) was a huge success! Over 50 GISTers and their families gathered for a great day of learning, and sharing experiences. It was wonderful to get to meet so many new people and reconnect with old friends.
LRG Canada holds first GIST Day of Learning in Toronto
LRG Canada held it’s first GIST Day of Learning in November and Dr. David Josephy had nothing but great things to say the event...
Life Fest 2012 hits big in Las Vegas!
Life Fest 2012 was not only the premier gathering of the Life Raft Group community but a celebration of our ten year anniversary as well!
LRG Sets GDOL Miami Date for March
The second annual GIST Day of Learning will be held on March 23, 2013. This year we are privileged once again that Dr. Jonathan Trent of Sylvester Cancer Center in Miami has agreed to host our gathering and we are honored to hear what he has to say.
Understanding How GISTs Develop Enables Discovery of New Therapies
By Drs. Sebastian Bauer, West German Cancer Center, University of Essen, Germany and Jonathan Fletcher, Brigham & Women’s Hospital, Harvard University, LRG Research Team Researchers talk plainly about microGISTs, how this cancer develops and what all [...]
Understanding Drug Classes
Many new cancer drugs are entering clinical practice and clinical trials. Many GIST patients are no longer responding to Gleevec or Sutent and thus are looking for clinical trials. Understanding strategies and grouping these new drugs into classes with other similar drugs may help patients understand some of their choices.
Tips for Managing GIST for Older Adults
Co-Existing Conditions Co-existing conditions are medical illnesses or problematic conditions that a person has along with cancer, such as high blood pressure, diabetes, or depression. These conditions often influence how a person responds to treatment, [...]